Search Within

Charles Rudin

  1. "Radiology, Department of"
Formats
  1. Journal Article (53)
  2. Meeting Abstract (41)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (94)
  2. Department of Medicine (94)
  3. GSK Faculty (94)
  4. Radiology, Department of (94)
  5. Solid Tumor Oncology Division (94)
  6. Thoracic Oncology (94)

More Groups

People
  1. Mark Kris (40)
  2. Andrew Plodkowski (32)
  3. Michelle Ginsberg (26)
  4. Bob Li (25)
  5. Gregory Riely (25)
  6. Michael Offin (25)

More People

Years
  1. 2024 (9)
  2. 2023 (9)
  3. 2022 (11)
  4. 2021 (9)
  5. 2020 (15)
  6. 2019 (12)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. Journal of Thoracic Oncology (15)
  3. Clinical Cancer Research (12)
  4. Cancer Discovery (6)
  5. JCO Precision Oncology (4)
  6. Journal of Nuclear Medicine (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (25)
  2. American Association for Cancer Research (21)
  3. Elsevier Inc. (21)
  4. Nature Publishing Group (4)
  5. Oxford University Press (4)
  6. Society of Nuclear Medicine (4)

More Publishers

Results (94)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Response to crizotinib and cabozantinib in stage IV lung adenocarcinoma patients with mutations that cause MET exon 14 skipping
    Meeting Abstract

    Paik, P. K.; Drilon, A. E.; Yu, H. A.; Krug, L. M.; Rekhtman, N.; Borsu, L.; Ginsberg, M. S.; Berger, M. F.; Ladanyi, M.; Rudin, C. M.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II study of cabozantinib for patients with advanced RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A. E.; Sima, C. S.; Somwar, R.; Smith, R.; Ginsberg, M. S.; Riely, G. J.; Rudin, C. M.; Ladanyi, M.; Kris, M. G.; Rizvi, N. A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Response to MET inhibitors in patients with stage IV lung adenocarcinomas harboring met mutations causing exon 14 skipping
    Journal Article

    Paik, P. K.; Drilon, A.; Fan, P. D.; Yu, H.; Rekhtman, N.; Ginsberg, M. S.; Borsu, L.; Schultz, N.; Berger, M. F.; Rudin, C. M.; more...
    Cancer Discovery (2015)

    Fulltext@MSK | Save
  • Phase I trial of the hedgehog (Hh) inhibitor, LDE225, in combination with etoposide and cisplatin (EP) for initial treatment of extensive stage small cell lung cancer (ES-SCLC)
    Meeting Abstract

    Pietanza, M. C.; Krug, L. M.; Varghese, A. M.; Fleisher, M.; Teitcher, J. B.; Holodny, A.; Sima, C. S.; Litvak, A. M.; Ng, K. K.; Patel, P. R.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save